BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,650,603 | -52.4% | 371,378 | -40.1% | 2.06% | -39.7% |
| Q2 2023 | $39,184,000 | +30.0% | 620,000 | -7.5% | 3.42% | +37.9% |
| Q1 2023 | $30,143,300 | -53.4% | 670,000 | -54.7% | 2.48% | -50.5% |
| Q4 2022 | $64,742,418 | -42.2% | 1,477,800 | -13.1% | 5.02% | -31.8% |
| Q3 2022 | $112,013,000 | +92.8% | 1,700,000 | +47.8% | 7.36% | +49.8% |
| Q2 2022 | $58,087,000 | -41.3% | 1,150,000 | -25.8% | 4.91% | +10.6% |
| Q1 2022 | $99,014,000 | -40.4% | 1,550,000 | 0.0% | 4.44% | -5.1% |
| Q4 2021 | $166,021,000 | +4.2% | 1,550,000 | 0.0% | 4.68% | +17.9% |
| Q3 2021 | $159,356,000 | +16.9% | 1,550,000 | 0.0% | 3.97% | +14.6% |
| Q2 2021 | $136,338,000 | -9.5% | 1,550,000 | 0.0% | 3.46% | -22.9% |
| Q1 2021 | $150,707,000 | -13.3% | 1,550,000 | 0.0% | 4.49% | -12.8% |
| Q4 2020 | $173,833,000 | +21.0% | 1,550,000 | 0.0% | 5.15% | -20.0% |
| Q3 2020 | $143,685,000 | +18.8% | 1,550,000 | 0.0% | 6.43% | -10.1% |
| Q2 2020 | $120,900,000 | +33.4% | 1,550,000 | 0.0% | 7.16% | -25.6% |
| Q1 2020 | $90,644,000 | +20.4% | 1,550,000 | +64.9% | 9.62% | +38.9% |
| Q4 2019 | $75,303,000 | -99.9% | 940,000 | 0.0% | 6.92% | -3.1% |
| Q3 2019 | $69,061,800,000 | -22.1% | 940,000 | 0.0% | 7.15% | -13.9% |
| Q2 2019 | $88,670,200,000 | +130424.0% | 940,000 | +10.8% | 8.30% | +11.2% |
| Q1 2019 | $67,934,000 | +96.9% | 848,648 | +32.6% | 7.46% | +26.4% |
| Q4 2018 | $34,502,000 | -41.1% | 640,000 | -14.7% | 5.90% | -17.0% |
| Q3 2018 | $58,545,000 | +43.0% | 750,000 | +16.3% | 7.12% | +24.3% |
| Q2 2018 | $40,945,000 | +28.3% | 645,000 | +85.3% | 5.73% | +2.0% |
| Q1 2018 | $31,912,000 | +21.6% | 348,000 | 0.0% | 5.61% | -12.2% |
| Q4 2017 | $26,243,000 | +26.4% | 348,000 | +16.8% | 6.39% | +9.0% |
| Q3 2017 | $20,762,000 | +49.0% | 298,000 | +8.4% | 5.86% | +13.7% |
| Q2 2017 | $13,934,000 | +18.3% | 275,000 | -6.6% | 5.15% | -25.8% |
| Q1 2017 | $11,777,000 | +71.7% | 294,500 | +20.4% | 6.95% | +22.7% |
| Q4 2016 | $6,858,000 | -19.5% | 244,500 | -14.8% | 5.66% | -17.9% |
| Q3 2016 | $8,524,000 | +23.8% | 287,000 | -15.6% | 6.90% | +0.7% |
| Q2 2016 | $6,885,000 | +18.7% | 340,000 | +5.8% | 6.85% | +3.0% |
| Q1 2016 | $5,799,000 | -46.6% | 321,300 | -22.1% | 6.66% | -30.7% |
| Q4 2015 | $10,865,000 | – | 412,500 | – | 9.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |